Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.08 EUR | -5.98% | -8.39% | -6.55% |
Dec. 23 | Eurofins: 4th share buyback program | CF |
Nov. 28 | EUROFINS SCIENTIFIC : NAV cut by -6.0% |
Executive Committee: Eurofins Scientific SE
Manager | Positions heldSince | ||||
---|---|---|---|---|---|
Gilles Martin 62 year |
| ||||
Laurent Lebras |
| ||||
Christian Wurst |
|
Composition of the Board of Directors: Eurofins Scientific SE
Director | CommitteesSince | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gilles Martin 62 year |
| ||||||||
Patrizia Luchetta 61 year |
| ||||||||
Ivo Rauh |
| ||||||||
Pascal Rakovsky 66 year |
| ||||||||
Evie Roos 57 year |
| ||||||||
Yves-Loïc Martin 59 year |
| ||||||||
Valérie Hanote 59 year |
| ||||||||
Erica Monfardini |
|
Latest Appointments: Eurofins Scientific SE
Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer | 24-01-09 | MT |
Pacific Edge Names CEO | 21-10-28 | MT |
Eurofins Announces Board Appointments | 21-04-28 | CI |
Former Officers and Directors: Eurofins Scientific SE
Insider | Positions held SinceUntil | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandra Hoeylaerts |
| ||||||||||||
Richard Marchant |
| ||||||||||||
Stuart Anderson |
| ||||||||||||
Joanne Lau |
| ||||||||||||
Andreas König |
| ||||||||||||
Brandon Spradlin |
| ||||||||||||
Jennifer Ohayon |
| ||||||||||||
Robert Gorman |
| ||||||||||||
Pamela Antay |
| ||||||||||||
Ted Hull |
| ||||||||||||
Féréchté Pouchantchi |
| ||||||||||||
Stuart Anderson |
| ||||||||||||
Dirk Bontridder |
| ||||||||||||
Xavier Dennery |
| ||||||||||||
Matthias-Wilbur Weber |
| ||||||||||||
Florian Heupel |
| ||||||||||||
Stefan Eckhoff |
| ||||||||||||
Pascal Bombardieri |
| ||||||||||||
Stuart Morgan |
| ||||||||||||
Jos Lamers |
| ||||||||||||
Richard Linney |
| ||||||||||||
Markus Brandmeier |
| ||||||||||||
Luc Leroy |
| ||||||||||||
Wicher R. Wichers |
| ||||||||||||
Sylvain Besson |
| ||||||||||||
Hugues Vaussy |
|
Age distribution of managers
Parity Men Women
Male | 9 |
---|---|
Female | 4 |
Of which Executive Committee
Male | 3 |
---|---|
Female | 0 |
Of which Directors
Male | 4 |
---|---|
Female | 4 |